NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Teva Pharmaceutical Industries, which this week revealed plans to buy Allergan's (AGN.N) generics drugs business in a $40.5 billion deal, said on Thursday sales of its branded multiple sclerosis drug Copaxone rose 12 percent in the second quarter even though it faces new competition. Teva, the world's biggest generic drug…

news

Santhera Pharmaceuticals Holding AG to raise capital through sale of newly created shares. Announces intent to sell up to 300,000 registered shares of newly created treasury shares (representing 6.03 pct of company's total outstanding share capital). Proceeds will be used to finance commercial launch of raxone in leber's hereditary optic…

news

Shares of drugmaker Glenmark Pharmaceuticals surged over 6 per cent in trade on Friday, a day after the company posted an 11% rise in its first quarter revenue, driven by sales in India and Latin American markets. The stock hit an intraday high of Rs 1019.70 on the BSE. The…

news

Belgian pharmaceutical company UCB raised its 2015 forecasts on Friday as sales of its three major upcoming drugs propelled first-half earnings by more than expected. UCB said it now expected revenue this year of 3.65-3.75 billion euros, a 0.1 billion euro hike from before, recurring core profit (REBITDA) at the…

news

British investor Neil Woodford is backing a start-up biopharmaceutical firm whose first venture will be to launch clinical trials of three drugs developed by Novartis. London-based Mereo BioPharma Group, set up in March, aims to buy drugs discovered by big pharmaceutical companies and fund and design later-stage clinical trials. It…

news

The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday. "We believe that there should be a thoughtful, staged roll-out of this vaccine, particularly because it is important that we acquire more…

news

Sun Pharmaceutical Industries is cutting staff again as it digests the $3.2-billion acquisition of Ranbaxy Laboratories. Facing the axe this time are research and development staff, a move that comes a month after about 150 senior executives were asked to leave. Close to 15 employees from the R&D department are…

news

Drugmaker GlaxoSmithKline, which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania. GSK confirmed it was looking into the latest claims of improper payments set out in a whistleblower's email…

news

Hikma Pharmaceuticals is buying Boehringer Ingelheim's U.S. generic drugs business for about $2.65 billion in cash and stock, the latest in a string of deals in a sector where size can lend a competitive edge. The Jordanian company, which makes and markets branded and non-branded generic and injectable drugs, said…

news

Merck & Co Inc (MRK.N) reported a better-than-expected quarterly profit and boosted its full-year earnings forecast as demand for its diabetes and cancer drugs increased. The company also said it expects to reap benefits from its $8.4 billion purchase of Cubist Pharmaceuticals, the maker of blockbuster antibiotic Cubicin. Cubicin sales…